Certara Announces New Versions of Biosimulation Software for Development of Novel Biologics PRINCETON, N.J., June 21, 2022 (GLOBE NEWSWIRE) -- Certara Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the release of new versions of its Immunogenicity (IG),...

SomaLogic Announces New Collaboration with FDA to Advance Biosimilar Development BOULDER, Colo., Oct. 29, 2020 (GLOBE NEWSWIRE) -- SomaLogic, Inc. announced today an agreement with the US Food and Drug Administration (FDA)’s Division of Applied Regulatory Science to evaluate the...

Biosimilars Market To Reach USD 44.56 Billion By Year 2026 | Reports And Data Market Size – USD 5.10 Billion in 2018, Market Growth - CAGR of 30.8%, Market Trends – Product launches and research for advanced Biosimilars  NEW YORK, March 19, 2019 (GLOBE NEWSWIRE) -- ...